Navigation Links
When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research
Date:6/12/2009

Femmenessence: Proven to Regulate Hormone Levels in Women

SAN FRANCISCO, June 12 /PRNewswire/ -- Women approaching and exiting menopause are in a bind. As hormone levels fluctuate and decline, they experience a range of uncomfortable symptoms that can include hot flashes, night sweats, mood decline, and loss of libido. As common as these symptoms are, women's options for relief are limited. Researchers reported in 2002 that the hormone replacement therapy Prempro(R), which introduces foreign estrogens, obtained from pregnant mare's urine, into a woman's body, increased rates of breast cancer and stroke, (per JAMA 2002; 288:321-333.) causing American women to reject the drug en masse. While natural products that promise relief from menopausal symptoms abound, few have success rates higher than 50% and none have been clinically proven to regulate hormone levels; with one exception: Natural Health International's Femmenessence, made from the proprietary ingredient Maca-GO(R), www.naturalhi.com, a concentrated organically certified, proprietary formulation of the Peruvian herb maca.

Hormones are the body's directors, controlling the activity of cells and organs, affecting much more than just menopausal symptoms. "Hormones are profoundly important to a woman's health - hormones affect a woman's mood and cognitive function, they directly affect a woman's bone density, and hormones are without a doubt the most important factor of a woman's cardiovascular health," explains James Frame, CEO of Natural Health International (NHI), a vertically integrated San Francisco based health and dietary supplement company.

The subject of four published studies, the Femmenessence line includes two hormone-balancing products for women entering or leaving "the change of life": MacaLife(R) for peri-menopausal women experiencing hormonal fluctuatio
'/>"/>

SOURCE Natural Health International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
3. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
4. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
5. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
6. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
7. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
8. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
9. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
10. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
11. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...27 ACUO TECHNOLOGIES, developers o...re, data migration tools and services, is pleased ...emark Office has approved a patent application for...Network." Acuo Technologies is pleased to add the ...rty. In general, the granted patent application br...
(Date:11/25/2009)...Nov. 25 Praxis Electronic Medical ...can Academy of Family Physicians, (AAFP) Family Pr... Survey for improving medical quality, health main...new ARRA Stimulus legislation. Praxis also ranked ...ve effect in determining their salary. Finally, Pr...
(Date:11/25/2009)... 25 Hologic, Inc. (Holog...eloper, manufacturer and supplier of premium diagn...cts dedicated to serving the healthcare needs of w...cal Society of North America (RSNA) at McCormick P...009 to highlight our new SecurView(®) DX mult...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Gerton Lab determines the composition of centromeric chromatin 10126 1Gerton Lab determines the composition of centromeric chromatin 10126 2William Fuchs Named to PerfectServe Advisory Board 58395 1William Fuchs Named to PerfectServe Advisory Board 58395 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2
...n Phase 1/2 Trial of TRU-016, Trubion,s Proprietar...BI-087 for RA Expands Trubion,s Family of Customiz...ct Candidates, SEATTLE, March 27 Trubion Pharmac...t it has initiated a Phase 1/2,clinical trial of T...ar,ImmunoPharmaceutical (SMIP(TM)) drug candidate,...
... Encouraging Response in CF Patients - Results Va... Model, BETHESDA, Md., March 27 The Cystic Fibro...l drug in development that targets a,basic defect ...e 2a,clinical trial for patients who carry the G55...Vertex Pharmaceuticals Incorporated., Patients wh...
Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
(Date:11/27/2009)...v. 27 Shamir Optical Ind...g provider of innovative products and technology t... its board of directors had declared a dividend di...n (approximately NIS 37.62 million based on the No...or approximately US$ 0.609 (approximately NIS 2.3 ...
(Date:11/27/2009)...medical, economic burdens, study predicts , ...er of people with diabetes in the United States is...study predicts. , That would bring the total by...e, up from 23.7 million today. , , At the same t...l triple, the study also warns, rising from an est...
(Date:11/27/2009)...se bilingual coloring books designed for children ...munity to educate - inform parents and children al... Dinosuars to ABC,S and a host of other topics. ,...ovember 27, 2009 -- Today’s children have en...y any hour of the day, but one of the oldest and s...
(Date:11/26/2009)...wire/ -- With cold and flu season upon us, it,s mo... control the spread of infections and avoid illnes... ourselves healthy, but to avoid transmitting illn...IC (certified in infection-control), nursing direc...at Hospital for Special Surgery (HSS) in Manhattan...
(Date:11/26/2009)...hiomolybdate (TM) has been shown in studies to be ...sease caused by an overload of copper, and certain...le, however, is known about how the drug works at ...estern University researchers now has provided an ...f TM bound to copper-loaded metallochaperones. The...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
... HANOVER, N.H. A new Web site designed to emphasiz...ched through Children,s Hospital at Dartmouth (CHa...nline patient education site was created by Dartmo...grant, the siteNo Smoking Room.Org ( www.nosmoking...
...HESDA, Md., Nov. 13 The fourth annual EagleBank,F...over $100,000. The,following local hospitals were ...ospital and Suburban Hospital in Montgomery County... Primary Care,Coalition of Montgomery County. The ...
...KONKOMA, N.Y., Nov. 13 NBTY, Inc. (NYSE:,NTY) (h...r and marketer of,nutritional supplements, today a...mber of its Board of Directors, has adopted a pre-...he stock,trading plan was adopted in accordance wi...
...T LAUDERDALE, Fla., Nov. 13 eDiets.com,Inc. (Nasd...ome diet, fitness,and healthy lifestyle solutions,... nine months ended September 30, 2008., Revenues ...0.13) per diluted share, for the third quarter of ...
... DIEGO, Nov. 13, 2008 Amylin,Pharmaceuticals, Inc...d,Capital Markets Healthcare Conference in New Yor... Daniel M. Bradbury, president and chief executive...ilable following the event. The Web cast and recor...
...avioral counseling needs to go beyond merely urgin...DAY, Nov. 13 (HealthDay News) -- Teenage girls tre...highly vulnerable to sexually transmitted infectio...earchers, suggest that treating PID "with a prescr...
Other Medicine News:Health News:Innovative new Web site empowers young girls to live smoke-free 2Health News:Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 2Health News:NBTY Founder Adopts Rule 10b5-1 Trading Plan 2Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: